BR112012024120A2 - sarms e método de uso dos mesmos - Google Patents
sarms e método de uso dos mesmosInfo
- Publication number
- BR112012024120A2 BR112012024120A2 BR112012024120A BR112012024120A BR112012024120A2 BR 112012024120 A2 BR112012024120 A2 BR 112012024120A2 BR 112012024120 A BR112012024120 A BR 112012024120A BR 112012024120 A BR112012024120 A BR 112012024120A BR 112012024120 A2 BR112012024120 A2 BR 112012024120A2
- Authority
- BR
- Brazil
- Prior art keywords
- sarms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/730,094 US8309603B2 (en) | 2004-06-07 | 2010-03-23 | SARMs and method of use thereof |
PCT/US2011/029336 WO2011119544A1 (en) | 2010-03-23 | 2011-03-22 | Sarms and method of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012024120A2 true BR112012024120A2 (pt) | 2017-05-30 |
Family
ID=44673565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012024120A BR112012024120A2 (pt) | 2010-03-23 | 2011-03-22 | sarms e método de uso dos mesmos |
Country Status (12)
Country | Link |
---|---|
US (3) | US8309603B2 (pt) |
EP (1) | EP2549865A4 (pt) |
JP (2) | JP6199182B2 (pt) |
CN (1) | CN102905526A (pt) |
AU (1) | AU2011232660B2 (pt) |
BR (1) | BR112012024120A2 (pt) |
CA (1) | CA2793999C (pt) |
MX (1) | MX2012010972A (pt) |
NZ (1) | NZ602568A (pt) |
RU (2) | RU2015149196A (pt) |
WO (1) | WO2011119544A1 (pt) |
ZA (1) | ZA201207937B (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8853266B2 (en) * | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
US20070161608A1 (en) * | 2001-12-06 | 2007-07-12 | Dalton James T | Selective androgen receptor modulators for treating muscle wasting |
US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US20110237664A1 (en) * | 2004-06-07 | 2011-09-29 | Dalton James T | Selective androgen receptor modulators for treating diabetes |
US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US10010521B2 (en) | 2006-08-24 | 2018-07-03 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
EA016853B1 (ru) * | 2006-08-24 | 2012-08-30 | Юниверсити Оф Теннесси Рисерч Фаундейшн | Замещенные ациланилиды и их применение |
US7968603B2 (en) | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
CN103002737A (zh) * | 2010-01-11 | 2013-03-27 | Gtx公司 | 治疗睑板腺功能障碍的方法 |
WO2012106514A2 (en) * | 2011-02-03 | 2012-08-09 | Pop Test Cortisol Llc | System and method for diagnosis and treatment |
US20130122085A1 (en) * | 2011-11-03 | 2013-05-16 | Gtx, Inc. | Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof |
US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
DK2872482T3 (da) | 2012-07-13 | 2020-09-21 | Oncternal Therapeutics Inc | En fremgangsmåde til behandling af brystkræft med selektiv androgenreceptormodulator (sarm) |
US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
KR20210009438A (ko) * | 2012-09-27 | 2021-01-26 | 아라타나 세라퓨틱스, 인크. | 식욕부진을 조절 화합물 조성물 및 이의 이용 방법 |
CA2934772C (en) | 2013-12-23 | 2021-04-27 | Bcn Peptides, S.A. | Bicalutamide analogs or (s)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis |
KR20170097212A (ko) | 2015-01-28 | 2017-08-25 | 아라타나 세라퓨틱스, 인크. | 체중-증량 화합물의 장기 사용을 위한 조성물 및 방법 |
US10221911B2 (en) | 2016-07-19 | 2019-03-05 | Beijingwest Industries Co., Ltd. | Twin-tube hydraulic damper with a vibration suppressing device |
US10578183B2 (en) | 2017-01-24 | 2020-03-03 | Beijingwest Industries Co., Ltd. | Twin-tube hydraulic damper with a vibration suppressing device |
KR101949481B1 (ko) * | 2018-05-04 | 2019-05-02 | (주)케이앤씨바이오 | 사료섭취 증진제 조성물 및 그 제조방법 |
CN110679773A (zh) * | 2019-10-31 | 2020-01-14 | 华南农业大学 | 盐酸吡格列酮和l-肌肽在制备鸡饲料或其添加剂中的应用 |
CN114557315B (zh) * | 2022-02-11 | 2022-12-20 | 中国农业大学 | 一种降低动物胃产甲烷量的方法 |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3239345A (en) * | 1965-02-15 | 1966-03-08 | Estrogenic compounds and animal growth promoters | |
US4411890A (en) * | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
GB1360001A (en) | 1971-06-16 | 1974-07-17 | Scherico Ltd | Pharmaceutical compositions comprising substituted anilides |
US3875229A (en) * | 1972-11-24 | 1975-04-01 | Schering Corp | Substituted carboxanilides |
US4036979A (en) * | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
JPS6044294B2 (ja) | 1976-04-15 | 1985-10-02 | 帝国臓器製薬株式会社 | アニリド誘導体 |
US4139638A (en) * | 1976-09-23 | 1979-02-13 | Schering Corporation | Methods for the treatment of hirsutism |
EP0002309B1 (en) * | 1977-10-12 | 1982-12-01 | Imperial Chemical Industries Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
US4191775A (en) * | 1977-12-15 | 1980-03-04 | Imperial Chemical Industries Limited | Amide derivatives |
NZ197008A (en) | 1980-05-22 | 1984-10-19 | Ici Ltd | Acylanilide derivatives and pharmaceutical compositions |
JPS57171904A (en) * | 1981-04-15 | 1982-10-22 | Mitsubishi Petrochem Co Ltd | Tri- or tetra-substituted phenoxycarboxylic acid anilide type herbicide |
ATE28864T1 (de) * | 1982-07-23 | 1987-08-15 | Ici Plc | Amide-derivate. |
GB8617652D0 (en) * | 1986-07-18 | 1986-08-28 | Ici Plc | Acylanilide derivatives |
GB8617653D0 (en) | 1986-07-18 | 1986-08-28 | Ici Plc | Amide derivatives |
EP0400051B1 (en) | 1988-01-28 | 1995-05-10 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
WO1989007111A1 (en) | 1988-01-28 | 1989-08-10 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
US5162504A (en) * | 1988-06-03 | 1992-11-10 | Cytogen Corporation | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
US5179080A (en) * | 1989-08-31 | 1993-01-12 | Clinical Homecare, Corp. | Formulations containing growth hormone and nutritional supplements, and methods of treating malnutrition in chronic lung disease |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
FR2697841B1 (fr) | 1992-11-12 | 1995-01-13 | Rhone Poulenc Rorer Sa | Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent. |
CA2181358A1 (en) | 1994-01-21 | 1995-07-27 | Nancy M. Gray | Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US5656651A (en) * | 1995-06-16 | 1997-08-12 | Biophysica Inc. | Androgenic directed compositions |
CA2247946C (en) | 1996-04-04 | 2006-10-03 | Takeda Chemical Industries, Ltd. | Anticachectic composition |
WO1998005962A1 (en) | 1996-08-02 | 1998-02-12 | Panvera Corporation | A method for quantitating competitive binding of molecules to proteins utilizing fluorescence polarization |
US6071957A (en) * | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
US6995284B2 (en) | 2000-08-24 | 2006-02-07 | The University Of Tennessee Research Foundation | Synthesis of selective androgen receptor modulators |
US20050038110A1 (en) | 2000-08-24 | 2005-02-17 | Steiner Mitchell S. | Selective androgen receptor modulators and methods of use thereof |
US6492554B2 (en) * | 2000-08-24 | 2002-12-10 | The University Of Tennessee Research Corporation | Selective androgen receptor modulators and methods of use thereof |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
DE69815310T2 (de) | 1997-03-11 | 2004-04-22 | Les Laboratoires Aeterna Inc. | Zubereitungen zur tumorbehandlung enthaltend hai-knorpelextrakte und antineoplastische mittel |
WO1998053826A1 (en) | 1997-05-30 | 1998-12-03 | The University Of Tennessee Research Corporation | Non-steroidal agonist compounds and their use in male hormone therapy |
WO1998055153A1 (en) | 1997-06-04 | 1998-12-10 | The University Of Tennessee Research Corporation | Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging |
US5994409A (en) | 1997-12-09 | 1999-11-30 | U.S. Bioscience, Inc. | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds |
JP2002525268A (ja) | 1998-09-16 | 2002-08-13 | オンコファーマシューティカル, インコーポレイテッド | ゴルジ装置妨害剤の注射可能な処方物での腫瘍学的腫瘍の処置 |
US6548529B1 (en) * | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
JP2003511467A (ja) | 1999-10-14 | 2003-03-25 | ブリストル−マイヤーズ スクイブ カンパニー | アンドロゲンレセプターリガンド結合ドメインの結晶構造 |
KR100731566B1 (ko) | 1999-10-14 | 2007-06-22 | 가켄 세야쿠 가부시키가이샤 | 테트라히드로퀴놀린 유도체 |
HUP0203785A2 (hu) | 1999-10-19 | 2003-04-28 | Nobex Corporation | Eljárás Casodex enantiomereinek, származékainak és intermediereinek előállítására |
BR0015124A (pt) | 1999-10-27 | 2002-07-02 | Nobex Corp | Método de preparação de um enanciÈmero substancialmente puro |
US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
EP1299094A2 (en) | 2000-06-28 | 2003-04-09 | Bristol-Myers Squibb Company | Selective androgen receptor modulators and methods for their identification, design and use |
EP1401801B1 (en) * | 2000-08-24 | 2006-11-02 | The University Of Tennessee Research Corporation | Selective androgen receptor modulators and methods of use thereof |
US7919647B2 (en) | 2000-08-24 | 2011-04-05 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US20030232792A1 (en) | 2000-08-24 | 2003-12-18 | Dalton James T. | Selective androgen receptor modulators and methods of use thereof |
US7855229B2 (en) | 2000-08-24 | 2010-12-21 | University Of Tennessee Research Foundation | Treating wasting disorders with selective androgen receptor modulators |
US20020173495A1 (en) | 2000-08-24 | 2002-11-21 | Dalton James T. | Selective androgen receptor modulators and methods of use thereof |
US6838484B2 (en) * | 2000-08-24 | 2005-01-04 | University Of Tennessee Research Foundation | Formulations comprising selective androgen receptor modulators |
US7026500B2 (en) * | 2000-08-24 | 2006-04-11 | University Of Tennessee Research Foundation | Halogenated selective androgen receptor modulators and methods of use thereof |
US8008348B2 (en) | 2001-12-06 | 2011-08-30 | University Of Tennessee Research Foundation | Treating muscle wasting with selective androgen receptor modulators |
US7622503B2 (en) | 2000-08-24 | 2009-11-24 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US20030229099A1 (en) | 2000-08-30 | 2003-12-11 | Zhu Hugh Y. | Novel farnesyl protein transferase inhibitors as antitumor agents |
WO2002022585A1 (fr) | 2000-09-14 | 2002-03-21 | Kaken Pharmaceutical Co., Ltd. | Composes de tetrahydroquinoline |
US7318972B2 (en) * | 2001-09-07 | 2008-01-15 | Itm Power Ltd. | Hydrophilic polymers and their use in electrochemical cells |
US8853266B2 (en) | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
EP2289503B1 (en) | 2001-12-06 | 2016-06-29 | University of Tennessee Research Foundation | Treating muscle wasting with selective androgen receptor modulators |
BRPI0307699A2 (pt) | 2002-02-07 | 2015-06-16 | Gtx Inc | Tratamento de hiperplasia benigna da próstata com sarms. |
US7772433B2 (en) | 2002-02-28 | 2010-08-10 | University Of Tennessee Research Foundation | SARMS and method of use thereof |
IL163743A0 (en) | 2002-02-28 | 2005-12-18 | Univ Tennessee Res Foundation | Haloacetamide and azide substituted compounds and methods of use thereof |
GEP20074209B (en) | 2002-02-28 | 2007-10-10 | , | Multi-substitued selective androgen receptor modulators and methods of use thereof |
BR0308355A (pt) | 2002-03-13 | 2005-01-25 | Merck & Co Inc | Composto ou um sal farmaceuticamente aceitável ou um seu enanciÈmero, métodos para modular uma função mediada pelo receptor de androgênio em um mamìfero em necessidade de tal modulação, para ativar a função do receptor de androgênio em um mamìfero em necessidade de tal ativação, para tratar uma condição em um mamìfero, e para tratar osteoporose em um mamìfero em sua necessidade, composição farmacêutica, métodos para aumentar a densidade mineral óssea em um mamìfero em necessidade disto, para reduzir o risco de fraturas vertebrais ou não vertebrais em um mamìfero em necessidade disto, e para produzir um marcador de modificação óssea em um mamìfero em necessidade disto, processo para produzir uma composição farmacêutica, e, método para tratar ou prevenir uma condição artrìtica em um mamìfero em necessidade disto |
US20040224979A1 (en) | 2002-10-15 | 2004-11-11 | Dalton James T. | Treating obesity with selective androgen receptor modulators |
CN1726020A (zh) * | 2002-10-16 | 2006-01-25 | Gtx公司 | 用sarm治疗老年男性雄激素缺乏(adam)相关的疾病 |
US20040087810A1 (en) | 2002-10-23 | 2004-05-06 | Dalton James T. | Irreversible selective androgen receptor modulators and methods of use thereof |
US8309603B2 (en) * | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
AU2003300012A1 (en) * | 2002-12-30 | 2004-07-29 | Indiana University Research & Technology Corporation | Method of treatment for central nervous system injury |
EP1594490A4 (en) | 2003-01-22 | 2006-03-22 | Gtx Inc | TREATMENT OF WOMEN ANDROGEN DISEASE ASSOCIATED DISORDERS (ADIF) USING ANDROGENIC RECEPTOR MODULATORS (SARM) |
FI20030958A0 (fi) | 2003-06-27 | 2003-06-27 | Orion Corp | Uusia yhdisteitä |
US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
CA2541398C (en) | 2003-10-07 | 2012-08-21 | Eli Lilly And Company | Liquid formulations of ractopamine |
EA013738B1 (ru) | 2003-10-14 | 2010-06-30 | Юниверсити Оф Теннесси Рисерч Фаундейшн | Лечение нарушений костной ткани с использованием селективных модуляторов адрогенных рецепторов |
TW200523235A (en) | 2003-10-15 | 2005-07-16 | Gtx Inc | Anti-cancer compounds and methods of use thereof |
GB0328905D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
EP1631540A4 (en) | 2003-12-16 | 2006-10-04 | Gtx Inc | PRODRUGS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHOD OF USE THEREOF |
GEP20094851B (en) | 2004-06-07 | 2009-12-10 | The Univ Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US7825229B2 (en) | 2005-03-25 | 2010-11-02 | Rosetta Genomics Ltd. | Lung cancer-related nucleic acids |
JP2009506119A (ja) * | 2005-08-31 | 2009-02-12 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 選択的アンドロゲン受容体モジュレーターを用いる腎疾患、熱傷、創傷および脊髄損傷の処置 |
EP1991523B1 (en) | 2006-03-03 | 2012-08-15 | Orion Corporation | Selective androgen receptor modulators |
MX2009000385A (es) | 2006-07-12 | 2009-04-06 | Univ Tennessee Res Foundation | Acil-anilidas sustituidas y metodos de uso de las mismas. |
WO2008013791A2 (en) * | 2006-07-24 | 2008-01-31 | University Of Delaware | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
EA016853B1 (ru) | 2006-08-24 | 2012-08-30 | Юниверсити Оф Теннесси Рисерч Фаундейшн | Замещенные ациланилиды и их применение |
-
2010
- 2010-03-23 US US12/730,094 patent/US8309603B2/en not_active Expired - Fee Related
-
2011
- 2011-03-22 CN CN2011800255679A patent/CN102905526A/zh active Pending
- 2011-03-22 WO PCT/US2011/029336 patent/WO2011119544A1/en active Application Filing
- 2011-03-22 CA CA2793999A patent/CA2793999C/en not_active Expired - Fee Related
- 2011-03-22 RU RU2015149196A patent/RU2015149196A/ru unknown
- 2011-03-22 BR BR112012024120A patent/BR112012024120A2/pt not_active Application Discontinuation
- 2011-03-22 RU RU2012144842/04A patent/RU2571421C2/ru not_active IP Right Cessation
- 2011-03-22 AU AU2011232660A patent/AU2011232660B2/en not_active Ceased
- 2011-03-22 NZ NZ602568A patent/NZ602568A/en not_active IP Right Cessation
- 2011-03-22 MX MX2012010972A patent/MX2012010972A/es unknown
- 2011-03-22 JP JP2013501372A patent/JP6199182B2/ja not_active Expired - Fee Related
- 2011-03-22 EP EP11760029.6A patent/EP2549865A4/en not_active Withdrawn
-
2012
- 2012-09-26 US US13/627,900 patent/US8669286B2/en not_active Expired - Fee Related
- 2012-10-22 ZA ZA2012/07937A patent/ZA201207937B/en unknown
-
2014
- 2014-01-30 US US14/168,993 patent/US9278914B2/en not_active Expired - Fee Related
-
2015
- 2015-09-03 JP JP2015173657A patent/JP6078127B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP6199182B2 (ja) | 2017-09-20 |
CN102905526A (zh) | 2013-01-30 |
US9278914B2 (en) | 2016-03-08 |
US20100249228A1 (en) | 2010-09-30 |
EP2549865A4 (en) | 2015-11-04 |
ZA201207937B (en) | 2013-06-26 |
CA2793999C (en) | 2018-08-21 |
MX2012010972A (es) | 2013-06-13 |
WO2011119544A1 (en) | 2011-09-29 |
US20130035387A1 (en) | 2013-02-07 |
JP2013521830A (ja) | 2013-06-13 |
US20140221479A1 (en) | 2014-08-07 |
EP2549865A1 (en) | 2013-01-30 |
NZ602568A (en) | 2014-04-30 |
US8669286B2 (en) | 2014-03-11 |
AU2011232660A1 (en) | 2012-10-18 |
JP2015226549A (ja) | 2015-12-17 |
RU2015149196A (ru) | 2019-01-14 |
RU2012144842A (ru) | 2014-04-27 |
CA2793999A1 (en) | 2011-09-29 |
AU2011232660B2 (en) | 2014-10-23 |
US8309603B2 (en) | 2012-11-13 |
JP6078127B2 (ja) | 2017-02-08 |
RU2571421C2 (ru) | 2015-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012024120A2 (pt) | sarms e método de uso dos mesmos | |
BRPI1014544A2 (pt) | anticorpors anti-il-17f e metodos de uso dos mesmos | |
BR112013014119A2 (pt) | novos moduladores e métodos de uso | |
BR112014012590A2 (pt) | anticorpos anti-cd98 e métodos de uso dos mesmos | |
BR112013017980A2 (pt) | polipeptídeos de imunoglobulina marcado com aldeído e método de uso dos mesmos | |
BR112013007506A2 (pt) | piridinonas/pirazinonas - métodos de criação e de uso | |
BR112014009006A2 (pt) | compostos heterocíclicos e métodos de uso dos mesmos | |
BR112013013167A2 (pt) | inibidores de bromodomínio e usos dos mesmos | |
BR112013018333A2 (pt) | sistemas e métodos de âncora ajustável | |
BRPI0917891A2 (pt) | antagonistas de pd-1 e métodos de utilização dos mesmos | |
BR112013009489A2 (pt) | aparelho e método de conexão | |
BR112013026410A2 (pt) | compostos antimicrobianos e métodos de preparação e uso dos mesmos | |
FI20105901A0 (fi) | Laite ja menetelmä | |
CO6930362A2 (es) | Compuesto heterocíclico y su uso | |
BR112012031232A2 (pt) | método, dispositivo e uso | |
CO7020870A2 (es) | Anticuerpos anti-htra1 y métodos de uso | |
BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos | |
BR112013006016A2 (pt) | compostos de azabenzotiazol, composições e métodos de uso | |
BR112014003774A2 (pt) | inibidores de dyrk1 e usos dos mesmos | |
CO6862148A2 (es) | Composiciones transdérmicas de ibuprofeno y métodos de uso de las mismas | |
BR112014002716A2 (pt) | anticorpos anti-poliubiquitina e métodos de uso | |
BR112014001991A2 (pt) | certos inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso dos mesmos | |
CO7000747A2 (es) | Anticuerpos anti-lrp5 y métodos de uso | |
BR112013014235A2 (pt) | anticorpos anti-ccr4 e usos dos mesmos | |
BRPI1006857A2 (pt) | agentes de limpeza para limpeza de poços e métodos de uso dos mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |